How should hypotension be managed in a patient on continuous renal replacement therapy with a blood flow rate of 280 mL/min?

Managing Hypotension During CRRT at 280 mL/min Blood Flow Rate

When hypotension occurs during continuous renal replacement therapy (CRRT) at a blood flow rate of 280 mL/min, immediately reduce the ultrafiltration rate and increase dialysis time rather than stopping therapy, while simultaneously addressing other RRT-related mechanisms beyond fluid removal. 1, 2

Understanding the Mechanism

Hypotension during CRRT is multifactorial and not solely due to excessive ultrafiltration, despite this being a common assumption 2:

• Multiple RRT-related mechanisms can precipitate hemodynamic instability, including alterations in cardiac output, systemic vascular resistance changes, and inflammatory mediator removal 2
• Blood flow reductions at 280 mL/min may occur undetected during peristaltic pumping and can contribute to circuit dysfunction, though this primarily affects filter life rather than directly causing hypotension 3
• CRRT initiation itself is associated with increased vasopressor requirements in the first 24 hours before plateauing, independent of ultrafiltration 4

Immediate Management Steps

1. Reduce Ultrafiltration Rate First

• Lower the net ultrafiltration rate while maintaining adequate dialysis time to achieve the same volume removal goal over a longer period 1
• Higher ultrafiltration rates are associated with greater risk of intradialytic hypotension 1
• Maintain mean arterial pressure (MAP) targets, as higher MAP is associated with better outcomes during CRRT 4

2. Extend Treatment Time

• Increase dialysis time to allow for gentler fluid removal at lower ultrafiltration rates 1
• This approach maintains volume control while improving vascular compensation and hemodynamic tolerance 1

3. Optimize Vascular Stability

The following interventions improve tolerance to ultrafiltration 1:

• Adjust dialysate sodium concentration cautiously - while lower dialysate sodium reduces interdialytic weight gain and blood pressure, it can paradoxically worsen intradialytic hypotension 1
• Ensure negative sodium balance during treatment to balance single-treatment hemodynamic stability with long-term volume control 1

4. Address Vasopressor Requirements

• Expect gradual decline in vasopressor needs after the initial 24 hours of CRRT, with an effect estimate of -0.004 μg/kg/min per hour 4
• Do not reflexively increase vasopressors without first addressing ultrafiltration rate 4
• Age and higher baseline vasopressor doses predict lower tolerance to CRRT 4

Critical Pitfalls to Avoid

• Do not assume hypotension is always from excessive ultrafiltration - multiple other mechanisms may be responsible, and the appropriate response may not be to reduce ultrafiltration, particularly in significantly fluid-overloaded patients 2
• Do not stop CRRT entirely - instead, adjust the prescription parameters 1
• Monitor for undetected blood flow reductions at the 280 mL/min setting, as these occur frequently (0.59 episodes/hour) and may signal circuit problems 3

Special Considerations for Chronically Hypotensive Patients

For patients with baseline hypotension 1:

• Increase dialysis time as the primary intervention
• Consider whether peritoneal dialysis might be better tolerated than CRRT, though evidence is limited 1
• Adjust antihypertensive medications and liberalize salt intake if appropriate 1

Monitoring Parameters

Track the following to guide ongoing management 4:

• Hourly urine output (expect progressive decline with CRRT)
• Fluid balance trending toward neutrality
• MAP stability
• Vasopressor dose trajectory